Literature DB >> 10954556

CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.

G G Olinger1, M Saifuddin, G T Spear.   

Abstract

The ability of human immunodeficiency virus strain MN (HIV(MN)), a T-cell line-adapted strain of HIV, and X4 and R5 primary isolates to bind to various cell types was investigated. In general, HIV(MN) bound to cells at higher levels than did the primary isolates. Virus bound to both CD4-positive (CD4(+)) and CD4-negative (CD4(-)) cells, including neutrophils, Raji cells, tonsil mononuclear cells, erythrocytes, platelets, and peripheral blood mononuclear cells (PBMC), although virus bound at significantly higher levels to PBMC. However, there was no difference in the amount of HIV that bound to CD4-enriched or CD4-depleted PBMC. Virus bound to CD4(-) cells was up to 17 times more infectious for T cells in cocultures than was the same amount of cell-free virus. Virus bound to nucleated cells was significantly more infectious than virus bound to erythrocytes or platelets. The enhanced infection of T cells by virus bound to CD4(-) cells was not due to stimulatory signals provided by CD4(-) cells or infection of CD4(-) cells. However, anti-CD18 antibody substantially reduced the enhanced virus replication in T cells, suggesting that virus that bound to the surface of CD4(-) cells is efficiently passed to CD4(+) T cells during cell-cell adhesion. These studies show that HIV binds at relatively high levels to CD4(-) cells and, once bound, is highly infectious for T cells. This suggests that virus binding to the surface of CD4(-) cells is an important route for infection of T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954556      PMCID: PMC116367          DOI: 10.1128/jvi.74.18.8550-8557.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.

Authors:  H Sato; J Orenstein; D Dimitrov; M Martin
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

Review 2.  Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.

Authors:  M L Dustin; T A Springer
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

3.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

4.  Characterization of recombinant human interleukin-2 with micromethods.

Authors:  H W Lahm; S Stein
Journal:  J Chromatogr       Date:  1985-06-19

5.  Adsorption of Rous sarcoma virus to genetically susceptible and resistant chicken cells studied by laser flow cytometry.

Authors:  M F Notter; J F Leary; P C Balduzzi
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

6.  Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells.

Authors:  R Schlegel; M C Willingham; I H Pastan
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

7.  Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus.

Authors:  W J Morrow; M Wharton; R B Stricker; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1986-09

8.  Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect.

Authors:  J S McDougal; M Hubbard; J K Nicholson; B M Jones; R C Holman; J Roberts; D B Fishbein; H W Jaffe; J E Kaplan; T J Spira
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

9.  Quantitation of human immunodeficiency virus type 1 infection kinetics.

Authors:  D S Dimitrov; R L Willey; H Sato; L J Chang; R Blumenthal; M A Martin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  24 in total

1.  DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions.

Authors:  S Pöhlmann; G J Leslie; T G Edwards; T Macfarlan; J D Reeves; K Hiebenthal-Millow; F Kirchhoff; F Baribaud; R W Doms
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  HIV load testing with small samples of whole blood.

Authors:  Katrin Steinmetzer; Thomas Seidel; Andreas Stallmach; Eugen Ermantraut
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

3.  DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets.

Authors:  Chawaree Chaipan; Elizabeth J Soilleux; Peter Simpson; Heike Hofmann; Thomas Gramberg; Andrea Marzi; Martina Geier; Elizabeth A Stewart; Jutta Eisemann; Alexander Steinkasserer; Katsue Suzuki-Inoue; Gemma L Fuller; Andrew C Pearce; Steve P Watson; James A Hoxie; Frederic Baribaud; Stefan Pöhlmann
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection.

Authors:  Jun Fu; Beverly E Sha; Larry L Thomas
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

5.  Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.

Authors:  Vijaya Madhavi; Marjon Navis; Amy W Chung; Gamze Isitman; Leia H Wren; Robert De Rose; Stephen J Kent; Ivan Stratov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

Review 6.  HIV infection: focus on the innate immune cells.

Authors:  Milena S Espíndola; Luana S Soares; Leonardo J Galvão-Lima; Fabiana A Zambuzi; Maira C Cacemiro; Verônica S Brauer; Fabiani G Frantz
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

7.  Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.

Authors:  Carole Elbim; Valerie Monceaux; Yvonne M Mueller; Mark G Lewis; Stephanie François; Ousmane Diop; Khadija Akarid; Bruno Hurtrel; Marie-Anne Gougerot-Pocidalo; Yves Lévy; Peter D Katsikis; Jerome Estaquier
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils.

Authors:  Mark Duval; Marshall R Posner; Lisa A Cavacini
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

9.  Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients.

Authors:  I Birgitta Sundell; Prasad S Koka
Journal:  J Stem Cells       Date:  2006

10.  Human erythrocytes selectively bind and enrich infectious HIV-1 virions.

Authors:  Zoltan Beck; Bruce K Brown; Lindsay Wieczorek; Kristina K Peachman; Gary R Matyas; Victoria R Polonis; Mangala Rao; Carl R Alving
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.